| Literature DB >> 24192320 |
Camille E Short1, Erica L James, Ronald C Plotnikoff.
Abstract
OBJECTIVE: Several physical activity interventions have been effective in improving the health outcomes of breast cancer survivors. However, few interventions have provided detailed descriptions regarding how such interventions work. To develop evidence-based practice in this field, detailed descriptions of intervention development and delivery is needed. This paper aims to (1) describe the theory-and evidence-based development of the Move More for Life program, a physical activity program for breast cancer survivors; and (2) serve as an exemplar for theory-based applied research.Entities:
Mesh:
Year: 2013 PMID: 24192320 PMCID: PMC4228316 DOI: 10.1186/1479-5868-10-124
Source DB: PubMed Journal: Int J Behav Nutr Phys Act ISSN: 1479-5868 Impact factor: 6.457
The nine-step tailoring process (adapted from Kreuter et al. [22])
| 1. Analysing the health problem | Understand the determinants of physical activity behaviour change |
| 2. Developing a program framework | Outline the program “blue print” and develop a detailed description of each intervention component |
| 3. Developing tailoring assessment | Develop assessment to measure participants status on key determinants |
| 4. Designing feedback | Specify the design characteristics of the tailored material |
| 5. Writing tailored messages | Outline unique characteristics of each message and write the tailored messages |
| 6. Creating tailored algorithms | Link the specific responses to each assessment question with the corresponding message using logic statements – e.g. “if this, then that” |
| 7. Automating the tailoring process | Assemble the computer program that generates tailored feedback |
| 8. Implementing the program | Produce accurate and timely tailored feedback |
| 9. Evaluating the program | Evaluate process, impact and outcome of the tailored program |
Correspondence between social cognitive theory constructs and behaviour change techniques in the Move More for Life intervention
| Confidence in ability to engage in PA (task self-efficacy) and to overcome barriers to PA (barrier self-efficacy) | • Facilitate action planning [ | • Activity at the end of each newsletter prompting participants to be specific about what, when and who they will be active with each week |
| • Provide specific instructions [ | ||
| • Reinforce efforts or progress towards goal behaviour [ | ||
| • Provide feedback on participants past behaviour [ | • Graphs in each newsletter displaying PA relative to the guidelines and past behaviour | |
| • Promote vicarious experience [ | ||
| | | • Testimonial illustrating success |
| External factors that influence (either positively or negatively) the PA behaviour of an individual | • Help secure social support in ways meaningful to individuals (note: planning social support and social change has been associated with lowering self-efficacy [ | • Written advice encouraging participants to think of 1 or 2 people in their immediate circle they could share their physical activity plan with (to increase encouragement and opportunities for practical help). |
| • Teach behaviour change skills that help individuals cope with environmental barriers e.g. time management [ | • Provision of contact details for breast cancer specific PA groups | |
| • Encouragement to form a concrete plan | ||
| | • Provide individuals with PA resources and encourage links with the community [ | |
| Knowledge of what PA to perform and possession of PA skills necessary to perform those activities | • Inform breast cancer survivors of PA guidelines [ | • Written feedback about whether or not participants are meeting the guidelines |
| | • Provide instructions on how to perform specific activities (e.g. stretching) [ | • A3 poster illustrating stretches and resistance-based exercises |
| Expected effects of PA behaviour | • Address misconceptions about the benefits of PA and promote outcomes that have functional meaning for the individual (e.g. reducing fatigue, managing weight) [ | • Provide overview of scientific evidence for the benefits of physical activity |
| • Provide overview of how much other breast cancer survivors are exercising | ||
| • Testimonial illustrating success | ||
| | • Facilitate social comparison [ | |
| Personal regulation of goal-directed PA behaviour, includes activities such as goal setting, self-monitoring, problem solving and self-reward | • Promote self-regulation behaviours [ | • A3 activity planner |
| • Encourage participants to set PA challenges for themselves | ||
| | • Encourage self-monitoring [ | |
| Learning from the experience of others, by watching the actions and outcomes of others PA behaviour | • Provide opportunities for vicarious experience via credible role models [ | • Expert advice sections from exercise physiologist and behavioural scientist |
| • Testimonial from breast cancer survivor | ||
Summary table of literature exploring physical activity correlates and predictors among BCS
| Demographics | |
| Income | • (+) |
| Age | • (+) |
| • (/) | |
| • (/) | |
| Education | • (/) |
| Marital status | • (/) |
| Health status | |
| Co-morbidities | • (-) |
| Weight | • (+) |
| • (-) | |
| • | |
| HRQL | • (+) |
| • | |
| Fatigue | • (-) |
| Time since diagnosis | • (/) |
| Stage of cancer | • (/) |
| Social cognitive | |
| Self-efficacy | • (+) |
| • | |
| • (+) | |
| • (+) | |
| Social support | • (+) |
| • (+) | |
| • (+) | |
| • (/) | |
| Intention | • (+) |
| • | |
| Personality | • (+) |
| • (+) | |
| • (+) | |
| Perceived control | • (/) |
| Outcome expectation | • (+) |
| • (+) | |
| Decisional balance | • (/) |
| Physical activity behaviour | |
| Pre-diagnosis PA level | • (-) |
| • (+) | |
| • | |
| Baseline PA level | • (+) |
Figure 1Newsletters 1–3 exemplar exercise poster, update card and activity planner, respectively.
Sample raw variable table from the study
| R_first.name | Participants first name | 20 characters |
| Empty = not entered | ||
| R_PA1.AR.ST_Sess | Average number of sessions per week individual performed strenuous activity at baseline. | 3 characters |
| Empty = not entered | ||
| R_PA1.AR.ST_Min | Average time of each session (in minutes) individual spent performing strenuous activity at baseline. | 5 characters |
| Empty = not entered | ||
| R_PA1.AR.Mo_Sess | Average number of sessions per week individual performed moderate activity at baseline. | 3 characters |
| Empty = not entered | ||
| R_PA1.AR.Mo_Min | Average time of each session (in minutes) individual spent performing moderate activity at baseline. | 5 characters |
| Empty = not entered | ||
| R_diability1 | Please rate how much your physical health limits your ability to engage in regular activity | 1 not at all limited |
| 2 a little limited | ||
| 3 somewhat limited | ||
| 4 mostly limited | ||
| 5 completely limited | ||
| Empty = not entered | ||
| R_PA.PrioD_AR_global | Has the amount of aerobic exercise you do changed since you were diagnosed with cancer? | 1 No, I do the same amount of aerobic activity now |
| 2 Yes, I do more aerobic exercise more now | ||
| 3 Yes, I do less aerobic exercise now | ||
| Empty = not entered |
Sample intermediate variable from the intermediate variable table using in
| I_PA1.AR.Guid_modvig | Whether or not participants are meeting the aerobic guidelines of 30 minutes a day over 5 sessions at baseline (accounting for additional benefit of vigorous activity): | IF (R_PA1.AR.ST_Sess + R_PA1.AR.Mo_Sess < 5) AND (R_PA1.AR.ST_Min (x2) + R_PA1.AR.Mo_Min ≤ 150 THEN 1 |
| (1)Not meeting the guidelines | ELSE IF R_PA1.AR.ST_Sess + R_PA1.AR.Mo_Sess ≥ 5) AND (R_PA1.AR.ST_Min (x2) + R_PA1.AR.Mo_Min ≥ 150 THEN 2 | |
| (2)Meeting the guidelines |
Sample feedback variable from the feedback variable table used in Move More for Life
| F_Aerobic_performance1 | IF I_PA1.AR.Guid_modvig = 1 AND R_diability1 = < 3 AND R_PA.PD_AR_global = 1 THEN 1 |
| ELSE IF I_PA1.AR.Guid_modvig = 1 AND R_diability1 = < 3 AND R_PA.PD_AR_global = 2 THEN 2 | |
| ELSE IF I_PA1.AR.Guid_modvig = 1 AND R_diability1 = < 3 AND R_PA.PD_AR_global = 3 THEN 3 | |
| ELSE IF I_PA1.AR.Guid_modvig = 1 AND R_diability1 = ≥3 AND R_PA.PD_AR_global = 1 THEN 4 | |
| ELSE IF I_PA1.AR.Guid_modvig = 1 AND R_diability1 = ≥3 AND | |
| Etc. |
Cost per development stage of the program
| Step 1 | | |
| Qualitative research | 2 months | $1,800 |
| Steps 2-7 | | |
| Newsletter design | 2 month | $3,380 |
| Copy-editing | 1 month | $2,400 |
| Computer programming | 2 months | $14,000 |
| Step 8 | | |
| 330 Newsletters | 1 month | $1381 |
| 250 Update cards | 1 week | $221 |
| 380 Exercise example posters | 1 week | $670 |
| 380 Activity planners | 1 week | $670 |
| 3,000 Logo stickers | 1 week | $500 |
| Total | 8 months | $21,022 |
Note: project team member’s time has not been costed.
Participant characteristics (n = 92)
| N | % | |
| Age, years | | |
| Mean | 56 | |
| Range | 34-74 | |
| Married, de facto | 78 | 79.6 |
| Completed University | 47 | 46.8 |
| Income > $1000 per week | 37 | 37.7 |
| Full-time employed | 23 | 23.4 |
| Born in Australia | 74 | 75.5 |
| Remote/regional location | 50 | 51.0 |
| | | |
| BMI, kg/m2 | | |
| Mean | 26.60 | |
| SD | 5.11 | |
| Months post (active) treatment | ||
| Mean | 40.91 | |
| SD | 39.01 | |
| Disease stage | | |
| 0 | 3 | 3.06 |
| 1 | 21 | 21.43 |
| 2 | 29 | 29.59 |
| 3 | 22 | 22.45 |
| 4 | 2 | 2.04 |
| unknown | 21 | 21.43 |
| Treatment | | |
| Surgery | 91 | 92.86 |
| Chemotherapy | 70 | 71.4 |
| Radiotherapy | 67 | 68.4 |
| Hormones | 55 | 56.1 |
| | | |
| Aerobic exercise > 150 min/wk + 5 or more sessions? | 23 | 23.5 |
| Resistance exercise > 6 exercises per week | 15 | 15.31 |
Individual factors associated with how participants rated the intervention materials
| | | ||||
|---|---|---|---|---|---|
| | | | | | |
| MVPA (mins) | | 0.99 (0.99-1.00) | 0.389 | 1.01 (1.00-1.01) | 0.021* |
| Resistance training score | | 1.11 (1.03-1.19) | 0.006† | 1.12 (1.01-1.24) | 0.024* |
| Sitting weekday (mins) | | 0. 99 (0.99-0.99) | 0.035* | 0.99 (0.98-0.99) | 0.001† |
| Sitting weekend (mins) | | 0.99 (0.99-1.00) | 0.439 | 0.99 (0.99-1.00) | 0.998 |
| | | | | | |
| Age | | 0.98 (0.84-1.12) | 0.851 | 0.96 (0.81-1.14) | 0.663 |
| Marital status | Not married | 7.08 (0.79-63.42)× | 0.080 | 0.05 (0.00-0.94) | 0.046* |
| Live with children | Yes | 0.46 (0.72- 2.91) | 0.410 | 0.026 (0.03-1.80) | 0.175 |
| Income | $1000+ per week | 0.36 (0.06-2.06) | 0.257 | 0.45 (0.06-3.45) | 0.447 |
| Employment | Not working | 0.04 (0.01-0.33) | 0.002† | 1.39 (0.18-10.77) × | 0.748 |
| Education | Secondary school | . | . | . | . |
| Certificate or diploma | 1.26 (0.11-13.88) × | 0.845 | 0.19 (0.01-2.98) | 0.240 | |
| University degree | 0.65 (0.07-5.44) | 0.694 | 0.07 (0.00-1.39) | 0.083 | |
| Born in Australia | No | 1.03 (0.16- 6.51) | 0.973 | 0.43 (0.05-3.34) | 0.428 |
| PA Environment | | 0.95 (0.81-1.11) | 0.556 | 1.10 (0.92-1.31) | 0.269 |
| Geographical location | Major City | 6.08 (1.03- 35.56) × | 0.045* | 0.97 (0.16-5.74) | 0.974 |
| | | | | | |
| Outcome expectation | | 1.03 (0.86-1.21) | 0.767 | 1.02 (0.84-1.23) | 0.828 |
| Outcome expectancy | | 1.07 (0.81-1.41) | 0.622 | 1.42 (1.02-1.97) | 0.034* |
| Task Self-efficacy | | 0.97 (0.79-1.18) | 0.792 | 0.73 (0.56-0.96) | 0.026* |
| Barrier Self-efficacy | | 0.99 (0.92- 1.07) | 0.885 | 0.95 (0.88-1.03) | 0.301 |
| Family social support | | 1.02 (0.94-1.10) | 0.600 | 0.92 (0.84-1.02) | 0.129 |
| Friend social support | | 1.01 (0.92-1.09) | 0.858 | 1.03 (0.94-1.13) | 0.446 |
| Behavioural control | | 0.79 (0.65-0.97) | 0.028* | 0.79 (0.62-1.01) | 0.058~ |
| Self-regulation | | 1.07 (0.97-1.19) | 0.153 | 1.04 (0.92-1.17) | 0.475 |
| Action planning | | 0.92 (0.72-1.17) | 0.514 | 1.11 (0.84-1.47) | 0.454 |
| Observational learning | | 0.38 (0.15- 0.94) | 0.038* | 0.59 (0.17-2.05) | 0.410 |
| | | | | | |
| BMI | | 1.09 (0.89-1.34) | 0.377 | 0.89 (0.70-1.14) | 0.382 |
| Quality of life (Fact-B) | | 0.99 (0.92-1.07) | 0.968 | 1.06 (0.99-1.14) | 0.069~ |
| Fatigue (Facit) | | 1.07 (0.93- 1.22) | 0.308 | 1.05 (0.93-1.18) | 0.410 |
| Time since treatment (months) | | 1.00 (0.98-1.03) | 0.401 | 0.99 (0.96-1.01) | 0.593 |
| Radiotherapy | No | 0.12 (0.02-0.72) | 0.021* | 0.47 (0.06-3.48) | 0.463 |
| Chemotherapy | No | 1.93 (0.25-14.70) × | 0.523 | 0.84 (0.84-8.22) × | 0.878 |
| Hormone therapy | No | 18.89 (2.94-121.11 )× | 0.002† | 0.81 (0.14-4.64) × | 0.814 |
P= marginally significant; P* = < 0.05; P† ≤ 0.01; OR (CI)×= wide confidence interval (interpret with caution).